Malignant pleural mesothelioma: a phase II trial with docetaxel.

Vorobiof, D A

Malignant pleural mesothelioma: a phase II trial with docetaxel. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Mar 2002 - 412-5 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article

0923-7534

10.1093/annonc/mdf046 doi


Adolescent
Adult
Aged
Antineoplastic Agents, Phytogenic--adverse effects
Carcinoma--drug therapy
Docetaxel
Female
Gastrointestinal Diseases--chemically induced
Hematologic Diseases--chemically induced
Humans
Male
Mesothelioma--drug therapy
Middle Aged
Paclitaxel--adverse effects
Pleural Neoplasms--drug therapy
Survival Rate
Taxoids